...门静脉化疗 [gap=1153]in tumor thrombus;Transcatheter Arterial Chemoembolization;Drug Delivery System;portal vein chemotherapy ...
基于24个网页-相关网页
...-2000、RF-3000射频仪进行射频治疗,联合治疗组(联合组)共23例,在射频治疗的同时行经皮穿刺门静脉化疗(portal vein chemotherapy,PVC),并在治疗后第10天、第1、2、3、6个月在局麻下各行PVC一次。
基于10个网页-相关网页
...-cnki翻译助手 ）经肝动脉灌注化疗（transcatheter arterial chemotherapy,TAC）联合门静脉灌注化疗（portal vein chemotherapy,PVC）对大鼠种植性肝癌的治疗效果； 短句来源 cases of advanced gastric..
基于4个网页-相关网页
...防复发的价值(临床应用) 后联合肝动脉化疗栓塞(hepaticartery chemoembo-lization, HACE)和门静脉化疗(portal vein chemotherapy, PVC)对预防术后复发的价值 ..
基于2个网页-相关网页
received simple portal vein chemotherapy 门静脉灌注化疗
portal vein chemotherapy or chemoembolization 门静脉化疗或化疗栓塞
portal vein infusion chemotherapy 门静脉插管化疗
Conclusions the local infusion chemotherapy via hepatic artery and portal vein was an effective therapy for those who could not undergo the resection of advanced liver cancer.
结论肝动脉局部灌注化疗对不能手术切除的晚期肝癌，作为治疗手段不失为一种有效的方法。
Conclusion Double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma may ameliorate symptoms and prolong survival time.
结论中晚期不能切除的原发性肝癌使用肝动脉、门静脉双重插管灌注化疗，可以改善临床症状、延长存活期。
Methods: 49 patients with late liver carcinoma were treated with embolism of hepatic artery and combined with chemotherapy through portal vein were reported.
方法：49 例无手术指征肝癌患者，行单纯肝动脉栓塞与在肝动脉栓塞的基础上行肝门静脉化疗的对照研究。
应用推荐